Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AHQJW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN106188293A ADC-14
|
|||||
| Synonyms |
CN106188293A_ADC 14
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 4 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
1-2
|
|||||
| Antibody Name |
Anti-MET mAb Ab-11
|
Antibody Info | ||||
| Antigen Name |
Hepatocyte growth factor receptor (MET)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
CN106188293A_ADC-14LacNAc-based glycosite-specific conjudate through reduced inter-chain cysteines
|
|||||
